Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Organ protection in PSMA-targeted radionuclide therapy of prostate cancer

Organ protection in PSMA-targeted radionuclide therapy of prostate cancer

US Patent 11167049 · Granted Nov 9, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Trifunctional constructs with tunable pharmacokinetics useful in imaging and ant2025
System and method for automated processing of electronic records with machine le2025
18F-labeled peptide ligands useful in PET and Cerenkov luminescene imaging2025
Trifunctional constructs with tunable pharmacokinetics useful in imaging and ant2025
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2025
Double targeted constructs to affect tumor kill2025
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2024
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK2024
Triazine based radiopharmaceuticals and radioimaging agents2023
Triazine based radiopharmaceuticals and radioimaging agents2023
Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti2022
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2022